Dr. Samadi Advises on the Evolution and Future of Prostate Cancer Diagnosis
In the latest issue of his quarterly patient newsletter, Dr. David Samadi, a world renowned prostate cancer surgeon and urologist reveals the evolution of prostate cancer diagnoses.
This news letter reveals the positives about the Prostate Specific Antigen (PSA) test and also its negatives. Particularly, the doctor points out issues relating to the ongoing debate about the recent recommendation of the US Preventive Services Task Force.
The following is an extract revealing the firm advises this international reputable surgeon made on the evolution of prostate cancer diagnoses:
Internationally recognized Mount Sinai robotic prostate cancer surgeon, Dr. David Samadi, continues to “walk the talk” with his quarterly patient newsletter. The latest issue takes a frank look at the prostate-specific antigen (PSA) test and the changing face of prostate cancer screening and prostate cancer treatment.
The reputation of the PSA blood test seems to fluctuate monthly. Shortly after a U.S. government task force firmly advised against routine screening of healthy men, new reports emerge in support of the PSA. Some government data now points to PSA success in reducing the number of advanced-stage prostate cancer diagnoses by as much as three times.
The newsletter is just another example of the lifelong commitment of care that Dr. Samadi and his team make to each patient. “Even when patients overcome prostate cancer, information is still vital,” he stresses, “What we share with our patients could be infinitely helpful to other members of their family – their brothers, their sons. We take that responsibility very seriously.”
Dr. Samadi routinely supports use of the PSA test, but in his summer newsletter he takes a candid look at just how far the PSA can take us and shares exciting news about the future of prostate cancer diagnostics.
Dr. Samadi’s PSA Evolution article touches on the heavily debated limitations of the PSA, chief among them its inability to accurately stage the disease upon diagnosis. Without precision regarding a man’s prostate cancer severity, treatment decisions, including whether or not to have robotic prostatectomy surgery, are up to the surgeon’s and patient’s best call.
With an eye to the future, Dr. Samadi gives patients a broad overview of prostate cancer screening advancements and how we may soon have the power to make even more informed treatment decisions.
“We hear a lot about gene therapy,” says Dr. Samadi, “and it truly is the future of medicine. Genetic analysis teaches us more about prostate cancer every day. Methodology involving CNVs and various proteins in the body are going to change the way we diagnose prostate cancer and fight it.”
Copy Number Variations (CNVs) in prostate cancer tumor cells are soon-to-be sources of guidance for predicting how the disease will progress, while SPDEF proteins are beginning to define what enables – and ultimately, prevents – metastases.
The Robotic Oncology Newsletter also reminds patients how PSA Velocity Risk Count and post-treatment PSA screening contribute to lifelong wellness.
Dr. David Samadi is Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at Mount Sinai Medical Center in New York and innovator of the SMART technique (Samadi Modified Advanced Robotic Technique) robotic prostatectomy surgery. Source.
The above extract summarizes details of the latest quarterly newsletter by Dr. David Samadi. You will find this publication very useful if you or your loved one has prostate cancer.
The advice contained therein is invaluable especially as it will help you get more facts about diagnoses of prostate cancer in the future.
The evolution of prostate cancer diagnosis is ticking towards better and safer treatment for this disease of which about 30,000 men will die from this year according to the American Cancer Society.
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:
(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)
- Follow – Up Bladder Surgery Not Likely with Robotic Prostate Cancer Surgery – Dr. David Samadi
- Prostate Cancer and Bone Health – Dr. Samadi Calls for Increased Awareness and Comprehensive Treatment
- SMART – A Robotic Approach to Get Rid of Prostate Cancer
- Robotic Prostate Surgery Yields Better Survival Rates Than Radiation Treatment – A World-Renowned Prostate Cancer Expert Reports
- 4000th Robotic-Assisted Radical Prostatectomy to Be Performed By The Inventor Of SMART
- Prostate Cancer Treatment Early Can Save Life And Money
- Better Personalized Prostate Cancer Treatment In The Offing With New Testing Method
- New MRI Imaging Provides Better Diagnosing For Prostate Cancer
- Prostate Cancer Reminders and Prevention Tips are Father’s Day Perfect Gifts
- Cryothrapie Cancer Prostate Treatment – Present and Future Prospects
- Living With Prostate Cancer – Diagnosis During and After Treatment